Cell & Matter is a developer of cryopreservation technology designed to facilitate the preservation of eukaryotic cells. Their technology assists in obtaining optimal survival yields while keeping unchanged the biological properties for all cell types used in research, thereby enabling researchers to improve the success rate of biological research and cell therapy.

Vision and Mission: While specific vision and mission statements for Cell & Matter are not publicly available, their technological focus suggests a commitment to advancing the field of cryopreservation to support research and therapeutic applications. Their mission likely involves providing reliable and efficient cell preservation solutions to enhance the biological safety and success rates of cell-based therapies and research.

Noteworthy Points:

• Cell & Matter was founded in 2017 and has since become an operating subsidiary through acquisition.
• The company has a team of 15 employees and has been involved in multiple funding rounds, indicating steady growth and investor confidence.
• Cell & Matter’s technology is pivotal in improving the success rate of biological research and cell therapy, which is essential for the advancement of medical science and healthcare.